94/100BRaymond James Financial stock forecast 2027–2030
Analysts' average 12-month price target for Raymond James Financial is 170.00, 4.4% above the current price of 162.80. Their targets range from 164.00 to 179.00.
Of the 12 firms that rated Raymond James Financial in the past 12 months, 3 rate it buy or strong buy, 9 hold and 0 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 164.00 to 179.00, with an average of 170.00.
| Strong buy | 0 | |
| Buy | 3 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 179.00 |
| Average target | 170.00 |
| Lowest target | 164.00 |
| Current price | 162.80 |
Raymond James Financial price target history
Have analysts recently raised or lowered their Raymond James Financial price target and rating?
How analysts rate Raymond James Financial, month by month
3 of 12 firms rate it buy now, against 2 of 10 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Raymond James Financial analyst upgrades, downgrades and price targets
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 30 Oct 2026 | Truist Financial David Smith | Reiterated · Hold | 166.00 → 165.00 | -0.6% | 161.29 |
| 29 Oct 2026 | Raymond James Daniel Fannon | — | 197.00 → 164.00 | -16.8% | 157.38 |
| 13 Oct 2026 | Truist Financial David Smith | Reiterated · Hold | 188.00 → 166.00 | -11.7% | 156.58 |
| 7 Oct 2026 | Raymond James | — | 160.00 → 197.00 | +23.1% | 159.53 |
| 7 Oct 2026 | UBS | Reiterated · Neutral | 184.00 → 179.00 | -2.7% | 159.53 |
| 1 Oct 2026 | Wells Fargo Daniel Welden | — | 172.00 | — | 159.76 |
| 1 Sept 2026 | Raymond James | — | 179.00 → 160.00 | -10.6% | 178.17 |
| 1 Sept 2026 | Truist Financial David Smith | — | 188.00 | — | 178.17 |
| 27 Jul 2026 | UBS | Reiterated · Neutral | 175.00 → 184.00 | +5.1% | 172.75 |
| 23 Jul 2026 | Raymond James Michael Cho | — | 175.00 → 179.00 | +2.3% | 164.91 |
| 23 Jul 2026 | Raymond James Brennan Hawken | — | 205.00 → 175.00 | -14.6% | 165.16 |
| 23 Jul 2026 | Raymond James Devin Ryan | — | 174.00 → 205.00 | +17.8% | 168.01 |
| 10 Jul 2026 | Raymond James | — | 192.00 → 174.00 | -9.4% | 169.45 |
| 9 Jul 2026 | Raymond James | — | 200.00 → 192.00 | -4.0% | 169.90 |
| 9 Jul 2026 | Raymond James | — | 155.00 → 200.00 | +29.0% | 165.35 |
| 8 Jul 2026 | UBS Michael Brown | Reiterated · Neutral | 166.00 → 175.00 | +5.4% | 166.58 |
| 28 May 2026 | Raymond James | — | 172.00 → 155.00 | -9.9% | 143.22 |
| 23 Apr 2026 | UBS | Reiterated · Neutral | 158.00 → 166.00 | +5.1% | 156.16 |
| 23 Apr 2026 | Raymond James | — | 171.00 → 172.00 | +0.6% | 155.91 |
| 10 Apr 2026 | Raymond James Michael Cyprys | — | 156.00 → 171.00 | +9.6% | 145.35 |
| 9 Apr 2026 | Raymond James | — | 165.00 → 156.00 | -5.5% | 148.14 |
| 8 Apr 2026 | Raymond James | — | 198.00 → 165.00 | -16.7% | 147.82 |
| 8 Apr 2026 | UBS | Reiterated · Neutral | 176.00 → 158.00 | -10.2% | 147.82 |
| 1 Feb 2026 | Raymond James | — | 191.00 → 198.00 | +3.7% | 165.86 |
| 28 Jan 2026 | Raymond James | — | 187.00 → 191.00 | +2.1% | 169.02 |
| 22 Dec 2025 | Raymond James Michael Cyprys | — | 196.00 → 187.00 | -4.6% | 163.01 |
| 11 Dec 2025 | UBS Michael Brown | — | 176.00 | — | 166.94 |
| 10 Dec 2025 | Raymond James | — | 194.00 → 196.00 | +1.0% | 165.79 |
Raymond James Financial EPS and revenue estimates
Analysts expect Raymond James Financial's EPS to grow 18.6% a year until 2028, faster than over the last 5 years (12.4% a year) and the last 3 years (14.3%).
Analysts expect Raymond James Financial's revenue to grow 4.3% a year until 2028, slower than over the last 5 years (12.4% a year) and the last 3 years (11.0%).
Revenue
EPS
Does Raymond James Financial beat earnings estimates?
On average, analysts' EPS estimate was 7.0% off the result, either way, and their revenue estimate 9.8%, over the last 12 quarters.
- EPS beats
- 66 / 110
- Revenue beats
- 70 / 106
- Average EPS surprise, last 12
- +5.4%
- Since
- April 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 28 Oct 2026 | 3.26 | 3.59 | +10.1% | 4.20B | 4.27B | +1.6% |
| Q3 FY2026 | 22 Jul 2026 | 2.93 | 3.14 | +7.2% | 3.87B | 3.93B | +1.5% |
| Q2 FY2026 | 22 Apr 2026 | 2.76 | 2.83 | +2.5% | 3.85B | 3.86B | +0.4% |
| Q1 FY2026 | 28 Jan 2026 | 2.83 | 2.86 | +1.1% | 3.81B | 3.74B | -2.0% |
| Q4 FY2025 | 22 Oct 2025 | 2.83 | 3.11 | +9.9% | 3.64B | 4.13B | +13.4% |
| Q3 FY2025 | 23 Jul 2025 | 2.37 | 2.18 | -8.0% | 3.38B | 3.79B | +12.1% |
| Q2 FY2025 | 23 Apr 2025 | 2.45 | 2.42 | -1.2% | 3.42B | 3.79B | +10.8% |
| Q1 FY2025 | 29 Jan 2025 | 2.62 | 2.93 | +11.8% | 3.48B | 3.98B | +14.5% |
| Q4 FY2024 | 23 Oct 2024 | 2.41 | 2.95 | +22.4% | 3.32B | 3.95B | +19.1% |
| Q3 FY2024 | 24 Jul 2024 | 2.32 | 2.39 | +3.0% | 3.24B | 3.71B | +14.5% |
| Q2 FY2024 | 24 Apr 2024 | 2.31 | 2.31 | 0.0% | 3.15B | 3.59B | +14.2% |
| Q1 FY2024 | 24 Jan 2024 | 2.26 | 2.40 | +6.2% | 3.06B | 3.48B | +13.6% |
Raymond James Financial stock price 2027–2030: scenarios
If Raymond James Financial's earnings keep growing at the 16.1% a year analysts expect to FY2028, it would earn about 22.60 a share in FY2030. At the P/E it has traded at over the last five years (12.3 to 16.4) that is 278.11 to 370.39 a share, or 306.63 at its average P/E of 13.6. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 14.33 | 176.34 | 194.42 | 234.85 |
| FY2028 | 16.75 | 206.18 | 227.32 | 274.60 |
| FY2029 (extrapolated) | 19.46 | 239.46 | 264.01 | 318.92 |
| FY2030 (extrapolated) | 22.60 | 278.11 | 306.63 | 370.39 |
Each year's EPS is the analysts' consensus to FY2028; the years after continue its 16.1% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (12.3, 13.6, 16.4).
Is Raymond James Financial stock undervalued or overvalued?
Raymond James Financial's P/E of 13.4 is below the middle of its 5-year range (10.9 to 17.5, median 14.4). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Buyers pay less for each point of growth than usual: a PEG of 0.7 on expected growth against 1.2 on its median P/E and past five years' growth. At its usual P/E (14.4 × EPS of 12.13), Raymond James Financial's fair value is 174.09; the price, 162.80, is 6.5% below it. Its forward P/E, on the consensus for FY2027, is 11.4.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (10.9 and 17.4). The price against its P/E range
- Price to earnings ratio (TTM)
- 13.42
- Five-year median P/E
- 14.37
- Five-year P/E range
- 10.9 – 17.5
- Forward P/E (FY2027)
- 11.36
- PEG ratio
- 0.83
- To the average target
- +4.4%
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.10146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% | |
| 108.445 | 201.41108Price 108.45248 | +85.7% |
Furthest below the fair value on each stock's page, updated every day.